Cargando…

Comparison of dried blood spot and plasma sampling for untargeted metabolomics

INTRODUCTION. Untargeted metabolomics holds significant promise for biomarker detection and development. In resource-limited settings, a dried blood spot (DBS)-based platform would offer significant advantages over plasma-based approaches that require a cold supply chain. OBJECTIVES. The primary goa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobin, Nicole H., Murphy, Aisling, Li, Fan, Brummel, Sean S., Taha, Taha E., Saidi, Friday, Owor, Maxie, Violari, Avy, Moodley, Dhayendre, Chi, Benjamin, Goodman, Kelli D., Koos, Brian, Aldrovandi, Grace M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340475/
https://www.ncbi.nlm.nih.gov/pubmed/34164733
http://dx.doi.org/10.1007/s11306-021-01813-3
_version_ 1783733781276917760
author Tobin, Nicole H.
Murphy, Aisling
Li, Fan
Brummel, Sean S.
Taha, Taha E.
Saidi, Friday
Owor, Maxie
Violari, Avy
Moodley, Dhayendre
Chi, Benjamin
Goodman, Kelli D.
Koos, Brian
Aldrovandi, Grace M.
author_facet Tobin, Nicole H.
Murphy, Aisling
Li, Fan
Brummel, Sean S.
Taha, Taha E.
Saidi, Friday
Owor, Maxie
Violari, Avy
Moodley, Dhayendre
Chi, Benjamin
Goodman, Kelli D.
Koos, Brian
Aldrovandi, Grace M.
author_sort Tobin, Nicole H.
collection PubMed
description INTRODUCTION. Untargeted metabolomics holds significant promise for biomarker detection and development. In resource-limited settings, a dried blood spot (DBS)-based platform would offer significant advantages over plasma-based approaches that require a cold supply chain. OBJECTIVES. The primary goal of this study was to compare the ability of DBS- and plasma-based assays to characterize maternal metabolites. Utility of the two assays was also assessed in the context of a case-control predictive model in pregnant women living with HIV. METHODS. Untargeted metabolomics was performed on archived paired maternal plasma and dried blood spots from n=79 women enrolled in a large clinical trial. RESULTS. A total of 984 named biochemicals were detected across both plasma and DBS samples, of which 627 (63.7%), 260 (26.4%), and 97 (9.9%) were detected in both plasma and DBS, plasma alone, and DBS alone, respectively. Variation attributable to study individual (R(2)=0.54, p<0.001) exceeded that of the sample type (R(2)=0.21, p<0.001), suggesting that both plasma and DBS were capable of differentiating individual metabolomic profiles. Log-transformed metabolite abundances were strongly correlated (mean Spearman rho=0.51) but showed low agreement (mean intraclass correlation of 0.15). However, following standardization, DBS and plasma metabolite profiles were strongly concordant (mean intraclass correlation of 0.52). Random forests classification models for cases versus controls identified distinct feature sets with comparable performance in plasma and DBS (86.5% versus 91.2% mean accuracy, respectively). CONCLUSION. Maternal plasma and DBS samples yield distinct metabolite profiles highly predictive of the individual subject. In our case study, classification models showed similar performance albeit with distinct feature sets. Appropriate normalization and standardization methods are critical to leverage data from both sample types. Ultimately, the choice of sample type will likely depend on the compounds of interest as well as logistical demands.
format Online
Article
Text
id pubmed-8340475
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-83404752022-06-23 Comparison of dried blood spot and plasma sampling for untargeted metabolomics Tobin, Nicole H. Murphy, Aisling Li, Fan Brummel, Sean S. Taha, Taha E. Saidi, Friday Owor, Maxie Violari, Avy Moodley, Dhayendre Chi, Benjamin Goodman, Kelli D. Koos, Brian Aldrovandi, Grace M. Metabolomics Article INTRODUCTION. Untargeted metabolomics holds significant promise for biomarker detection and development. In resource-limited settings, a dried blood spot (DBS)-based platform would offer significant advantages over plasma-based approaches that require a cold supply chain. OBJECTIVES. The primary goal of this study was to compare the ability of DBS- and plasma-based assays to characterize maternal metabolites. Utility of the two assays was also assessed in the context of a case-control predictive model in pregnant women living with HIV. METHODS. Untargeted metabolomics was performed on archived paired maternal plasma and dried blood spots from n=79 women enrolled in a large clinical trial. RESULTS. A total of 984 named biochemicals were detected across both plasma and DBS samples, of which 627 (63.7%), 260 (26.4%), and 97 (9.9%) were detected in both plasma and DBS, plasma alone, and DBS alone, respectively. Variation attributable to study individual (R(2)=0.54, p<0.001) exceeded that of the sample type (R(2)=0.21, p<0.001), suggesting that both plasma and DBS were capable of differentiating individual metabolomic profiles. Log-transformed metabolite abundances were strongly correlated (mean Spearman rho=0.51) but showed low agreement (mean intraclass correlation of 0.15). However, following standardization, DBS and plasma metabolite profiles were strongly concordant (mean intraclass correlation of 0.52). Random forests classification models for cases versus controls identified distinct feature sets with comparable performance in plasma and DBS (86.5% versus 91.2% mean accuracy, respectively). CONCLUSION. Maternal plasma and DBS samples yield distinct metabolite profiles highly predictive of the individual subject. In our case study, classification models showed similar performance albeit with distinct feature sets. Appropriate normalization and standardization methods are critical to leverage data from both sample types. Ultimately, the choice of sample type will likely depend on the compounds of interest as well as logistical demands. 2021-06-23 /pmc/articles/PMC8340475/ /pubmed/34164733 http://dx.doi.org/10.1007/s11306-021-01813-3 Text en https://creativecommons.org/licenses/by/4.0/This AM is a PDF file of the manuscript accepted for publication after peer review, when applicable, but does not reflect post-acceptance improvements, or any corrections. Use of this AM is subject to the publisher’s embargo period and AM terms of use. Under no circumstances may this AM be shared or distributed under a Creative Commons or other form of open access license, nor may it be reformatted or enhanced, whether by the Author or third parties. See here for Springer Nature’s terms of use for AM versions of subscription articles: https://www.springernature.com/gp/open-research/policies/accepted-manuscript-terms
spellingShingle Article
Tobin, Nicole H.
Murphy, Aisling
Li, Fan
Brummel, Sean S.
Taha, Taha E.
Saidi, Friday
Owor, Maxie
Violari, Avy
Moodley, Dhayendre
Chi, Benjamin
Goodman, Kelli D.
Koos, Brian
Aldrovandi, Grace M.
Comparison of dried blood spot and plasma sampling for untargeted metabolomics
title Comparison of dried blood spot and plasma sampling for untargeted metabolomics
title_full Comparison of dried blood spot and plasma sampling for untargeted metabolomics
title_fullStr Comparison of dried blood spot and plasma sampling for untargeted metabolomics
title_full_unstemmed Comparison of dried blood spot and plasma sampling for untargeted metabolomics
title_short Comparison of dried blood spot and plasma sampling for untargeted metabolomics
title_sort comparison of dried blood spot and plasma sampling for untargeted metabolomics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340475/
https://www.ncbi.nlm.nih.gov/pubmed/34164733
http://dx.doi.org/10.1007/s11306-021-01813-3
work_keys_str_mv AT tobinnicoleh comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics
AT murphyaisling comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics
AT lifan comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics
AT brummelseans comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics
AT tahatahae comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics
AT saidifriday comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics
AT owormaxie comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics
AT violariavy comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics
AT moodleydhayendre comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics
AT chibenjamin comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics
AT goodmankellid comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics
AT koosbrian comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics
AT aldrovandigracem comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics